-
EP3679025
European procedure
Extract from the Register of European Patents
EP About this file: EP3679025
| EP3679025 - SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.03.2023 Database last updated on 15.06.2024 | |
| Former | The patent has been granted Status updated on 02.04.2022 | ||
| Former | Grant of patent is intended Status updated on 18.11.2021 | ||
| Former | Examination is in progress Status updated on 12.03.2021 | ||
| Former | Request for examination was made Status updated on 12.06.2020 | ||
| Former | The international publication has been made Status updated on 16.03.2019 | ||
| Former | unknown Status updated on 28.09.2018 | Most recent event Tooltip | 10.03.2023 | No opposition filed within time limit | published on 12.04.2023 [2023/15] | Applicant(s) | For all designated states BioNTech SE An der Goldgrube 12 55131 Mainz / DE | [2022/22] |
| Former [2020/29] | For all designated states Biontech SE An der Goldgrube 12 55131 Mainz / DE | Inventor(s) | 01 /
HENRY, Christophe Malerwinkel 1 81479 Munich / DE | [2020/29] | Representative(s) | Müller, Christian Stefan Gerd ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2020/29] | Application number, filing date | 18769603.4 | 31.08.2018 | [2020/29] | WO2018EP73485 | Priority number, date | WO2017EP72353 | 06.09.2017 Original published format: PCT/EP2017/072353 | [2020/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019048353 | Date: | 14.03.2019 | Language: | EN | [2019/11] | Type: | A1 Application with search report | No.: | EP3679025 | Date: | 15.07.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.03.2019 takes the place of the publication of the European patent application. | [2020/29] | Type: | B1 Patent specification | No.: | EP3679025 | Date: | 04.05.2022 | Language: | EN | [2022/18] | Type: | B8 Corrected title page of specification | No.: | EP3679025 | Date: | 15.06.2022 | [2022/24] | Search report(s) | International search report - published on: | EP | 14.03.2019 | Classification | IPC: | C07D401/04, A61K31/437, A61P35/00 | [2020/29] | CPC: |
C07D401/04 (EP,IL,US);
C07D471/04 (IL,KR,US);
A61K31/437 (EP,IL);
A61K31/4738 (IL,KR);
A61P35/00 (EP,KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/29] | Extension states | BA | 16.03.2020 | ME | 16.03.2020 | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | SUBSTITUIERTE IMIDAZOCHINOLINE ALS TLR7-AGONISTEN | [2020/29] | English: | SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 | [2020/29] | French: | IMIDAZOQUINOLINES SUBSTITUÉES UTILISÉES EN TANT QU'AGONISTES DE TLR7 | [2020/29] | Entry into regional phase | 16.03.2020 | National basic fee paid | 16.03.2020 | Designation fee(s) paid | 16.03.2020 | Examination fee paid | Examination procedure | 16.03.2020 | Examination requested [2020/29] | 16.03.2020 | Date on which the examining division has become responsible | 11.03.2021 | Despatch of a communication from the examining division (Time limit: M04) | 15.07.2021 | Reply to a communication from the examining division | 19.11.2021 | Communication of intention to grant the patent | 15.03.2022 | Fee for grant paid | 15.03.2022 | Fee for publishing/printing paid | 15.03.2022 | Receipt of the translation of the claim(s) | Divisional application(s) | EP22169256.9 / EP4098652 | Opposition(s) | 07.02.2023 | No opposition filed within time limit [2023/15] | Fees paid | Renewal fee | 25.08.2020 | Renewal fee patent year 03 | 23.08.2021 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]US6573273 (CROOKS STEPHEN L [US], et al) [AD] 1-12* example - *; | [AD]WO2005051324 (3M INNOVATIVE PROPERTIES CO [US], et al) [AD] 1-12 * example -; claim - *; | [AD]WO2009118296 (4SC AG [DE], et al) [AD] 1-12 * example 1 * | by applicant | WO0076505 | US6573273 | US2003144283 | US6677349 | WO2005051324 | WO2009118296 | - S. M. BERGE et al., "Phannaceutical Salts", J. Pharm. Sci., (19770000), vol. 66, pages 1 - 19 | - Remington's Pharmaceutical Sciences, Maack Publishing Co. |